Acute Coronary Syndrome - ECAB

Acute Coronary Syndrome - ECAB
ISBN-10
8131231771
ISBN-13
9788131231777
Category
Medical
Pages
168
Language
English
Published
2012-07-26
Publisher
Elsevier Health Sciences
Author
R R Kasliwal

Description

Acute coronary syndrome (ACS) is the term for the clinical signs and symptoms of myocardial ischemia: unstable angina, non–ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI). Unstable angina and NSTEMI normally result from a partially or intermittently occluded coronary artery, whereas STEMI results from a fully occluded coronary artery. The patients present with a wide arena of signs and symptoms like chest pain, nausea/vomiting, exertional pain, palpitation, shortness of breath, fatigue, etc. Angina, or chest pain, continues to be recognized as the classic symptom of ACS. In unstable angina, chest pain normally occurs either at rest or with exertion and results in limited activity. Chest pain associated with NSTEMI is usually longer in duration and more severe than chest pain associated with unstable angina. The diagnosis of ACS is based on triad of clinical presentation, electrocardiography and cardiac biomarkers. Electrocardiography is the most important initial diagnostic procedure when doctors suspect an acute coronary syndrome. Findings on a 12-lead ECG help the practitioner to differentiate between myocardial ischemia, injury, and infarction, locate the affected area and assess related conduction abnormalities. But at the same front, the definition of unstable angina, NSTEMI and STEMI is based on the levels of cardiac biomarkers too. Acute coronary syndromes are medical emergencies that need prompt action. Half of deaths due to a heart attack occur in the first 3–4 hours after symptoms begin. The sooner treatment begins, the better the chances of survival. Anyone having symptoms that might indicate an acute coronary syndrome should obtain prompt medical attention. Management of ACS involves a spectrum of interventions. It encompasses cardiac monitoring, thrombolysis, antiplatelet therapy, anticoagulant therapy, reperfusion therapy and invasive investigation and revascularization therapy. Reperfusion therapy (percutaneous coronary intervention) mainly holds for the ST-elevation myocardial infarction. Prognosis of the ACS patients depends on the post-myocardial risk stratification. The main highlights of risk stratification are risk stratification scores, assessment of cardiac function and stress testing, and management.

Similar books

  • Interventional Cardiology
    By Sinha

    ... vessels Femoral access site complications May not be performed if aspirin/clopidogrel intolerance Preprocedural Management CAS requires careful patient selection, procedure planning, and. 64 ECAB Clinical Update: Cardiology.

  • ECAB Cardiorenal Syndrome - E-Book
    By Vijay Kher, Upendra Kaul

    Many terms for this organ crosstalk were suggested, such as cardiorenal syndrome, cardiorenal anemia syndrome and ... Four major syndromes which broadly represent acute cardiac dysfuncon include acute decompensated heart failure (ADHF), ...

  • Hotspots in Diabetes - ECAB
    By Ambady Ramachandran

    Acute Coronary Syndrome (ACS) Impaired glucose metabolism is also frequently observed subsequent to an acute event in non-diabetic subjects.19,20 We had shown that the prevalence of abnormal glucose tolerance among urban Asian Indians ...

  • Cardiometabolic Risk in India - ECAB
    By KM Prasanna Kumar

    Management This patient of type 2 diabetes has acute coronary syndrome. ST elevation in ECG with mildly elevated CK-MB indicates myocardial injury/ischemia. The fact that troponin is elevated indicates high risk in this patient.

  • Recent Advances in Metabolic Syndrome – I - ECAB
    By R R Kasliwal, Anoop Misra

    Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J 1998;19:1355–64. Seman LJ, DeLuca C, Jenner JL, et al. Lipoprotein(a)-cholesteroland coronary heart disease in the ...

  • Dealing with Depression in Medically-ill Patients - ECAB

    Biol Psychiatry 2003;54:227–40. Czarny MJ, Arthurs E, Coffie DF, et al. Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: a systematic review. PLoS One 2011;6:e27671. DiMatteo MR, Lepper HS, ...

  • Coronary Artery Disease - ECAB
    By R R Kasliwal

    The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries and Risk Factors in 1990 and Projected to 2020. ... How to Beat the Heart Disease Epidemic among South Asians.

  • Systemic Diseases & Renal Manifestations - ECAB
    By D S Rana

    Myeloperoxidase is a marker ofaltered myocyte metabolism, oxidave stress, and inflammaon, especially in acute coronary syndrome. Oxidave stress may cause myocyte apoptosis and necrosis, and it is associated with arrhythmias and ...

  • ECAB Gastrointestinal Hemorrhage - E-Book
    By Peush Sahni

    preferred for the management of GV as EVL cannot be safely used in this situation. The cyanoacrylate glue polymerizes and hardens ... Invariably, an ulcer forms at the site of ligaon and heals with a scar, causing obliteraon of varices.

  • Lipids in Diabetes - ECAB
    By S V Madhu

    Higher levels of trans fatty acids are known to produce systemic inflammation and endothelial dysfunction and may contribute to atherogenesis, acute coronary syndromes, insulin resistance, and dyslipidemia.14 Further studies are ...